Call Options Transactions Made in Q3 2023 in Revance Therapeutics, Inc. (RVNC)
This table provides information about the institutional ownership of Revance Therapeutics, Inc. (RVNC) during Q3 2023. The information is specifically focused on institutions that hold call options of Revance Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2023
Q3 2023
|
Centiva Capital, LP
New York, NY |
BUY
|
CALL |
50KNew |
$574K - $1.25M
|
50K
$128K
|
|
|
Nov 14, 2023
Q3 2023
|
Capital Fund Management S.A.
Paris, I0 |
BUY
|
CALL |
41.9KNew |
$481K - $1.05M
|
41.9K
$108K
|
|
|
Nov 14, 2023
Q3 2023
|
D. E. Shaw & Co., Inc.
New York, NY |
BUY
|
CALL |
30KNew |
$344K - $752K
|
30K
$77.1K
|
|
|
Nov 14, 2023
Q3 2023
|
Hunting Hill Global Capital, LLC
New York, NY |
BUY
|
CALL |
26.9KNew |
$309K - $674K
|
26.9K
$69.1K
|
|
|
Nov 09, 2023
Q3 2023
|
Citigroup Inc
|
BUY
|
CALL |
24.9K+ 15.57% |
$286K - $624K
|
185K
$475K
|
|
|
Nov 15, 2023
Q3 2023
|
Gts Securities LLC
New York, NY |
BUY
|
CALL |
14KNew |
$161K - $351K
|
14K
$36K
|
|
|
Nov 14, 2023
Q3 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
CALL |
12.2K+ 15.12% |
$140K - $306K
|
92.9K
$239K
|
|
|
Nov 14, 2023
Q3 2023
|
Cubist Systematic Strategies, LLC
Stamford, CT |
BUY
|
CALL |
9.5K+ 73.08% |
$109K - $238K
|
22.5K
$57.8K
|
|
|
Nov 14, 2023
Q3 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
CALL |
8.3K+ 6.84% |
$95.2K - $208K
|
130K
$333K
|
|
|
Nov 14, 2023
Q3 2023
|
Walleye Capital LLC
Plymouth, MN |
SELL
|
CALL |
-2.8K- 35.44% |
$32.1K - $70.2K
|
5.1K
$13.1K
|
|
|
Nov 14, 2023
Q3 2023
|
Walleye Trading LLC
Plymouth, MN |
SELL
|
CALL |
-10.3K- 56.59% |
$118K - $258K
|
7.9K
$20.3K
|
|
|
Nov 15, 2023
Q3 2023
|
Wolverine Trading, LLC
Chicago, IL |
SELL
|
CALL |
-10.7K- 38.49% |
$123K - $268K
|
17.1K
$43.9K
|
|
|
Nov 14, 2023
Q3 2023
|
Caption Management, LLC
Oklahoma City, OK |
SELL
|
CALL |
-262K- 45.89% |
$3M - $6.56M
|
308K
$792K
|